Gene · 9775
Papers1,749
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 1,749
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Research progress on RNA-binding proteins in breast cancer. | Oncol Lett | 2022 | 35261635 | PubTator, text mining | PubMed |
| Histone deacetylase inhibitors inhibit cervical cancer growth through Parkin acetylation-mediated mitophagy. | Acta Pharm Sin B | 2022 | 35256949 | PubTator, text mining | PubMed |
| Identification of DDX31 as a Potential Oncogene of Invasive Metastasis and Proliferation in PDAC. | Front Cell Dev Biol | 2022 | 35237592 | PubTator, text mining | PubMed |
| EIF4A3-mediated circPRKCI expression promotes triple-negative breast cancer progression by regulating WBP2 and PI3K/AKT signaling pathway. | Cell Death Discov | 2022 | 35236829 | PubTator, text mining | PubMed |
| Chimeric Peptides/Proteins Encoded by circRNA: An Update on Mechanisms and Functions in Human Cancers. | Front Oncol | 2022 | 35223470 | PubTator, text mining | PubMed |
| The Combined Effects of Circular RNA Methylation Promote Pulmonary Fibrosis. | Am J Respir Cell Mol Biol | 2022 | 35213290 | PubTator, text mining | PubMed |
| Identification of UBE2I as a Novel Biomarker in ccRCC Based on a Large-Scale CRISPR-Cas9 Screening Database and Immunohistochemistry. | Front Mol Biosci | 2022 | 35211510 | PubTator, text mining | PubMed |
| Predicting Heart Cell Types by Using Transcriptome Profiles and a Machine Learning Method. | Life (Basel) | 2022 | 35207515 | PubTator, text mining | PubMed |
| Downstream events initiated by expression of FSHD-associated DUX4: Studies of nucleocytoplasmic transport, γH2AX accumulation, and Bax/Bak-dependence. | Biol Open | 2022 | 35191484 | PubTator, text mining | PubMed |
| Regulation of Autophagy by the Glycogen Synthase Kinase-3 (GSK-3) Signaling Pathway. | Int J Mol Sci | 2022 | 35163631 | PubTator, text mining | PubMed |
| A Review of Current and Emerging Trends in Donor Graft-Quality Assessment Techniques. | J Clin Med | 2022 | 35159939 | PubTator, text mining | PubMed |
| The evolution of DUX4 gene regulation and its implication for facioscapulohumeral muscular dystrophy. | Biochim Biophys Acta Mol Basis Dis | 2022 | 35158020 | PubTator, text mining | PubMed |
| Comprehensive bioinformatics analysis identifies LAPTM5 as a potential blood biomarker for hypertensive patients with left ventricular hypertrophy. | Aging (Albany NY) | 2022 | 35157609 | PubTator, text mining | PubMed |
| Identification of tumour immune infiltration-associated snoRNAs (TIIsno) for predicting prognosis and immune landscape in patients with colon cancer via a TIIsno score model. | EBioMedicine | 2022 | 35144219 | PubTator, text mining | PubMed |
| Diagnostic efficacy of circular RNAs as noninvasive, liquid biopsy biomarkers for early detection of gastric cancer. | Mol Cancer | 2022 | 35139874 | PubTator, text mining | PubMed |
| circPTEN1, a circular RNA generated from PTEN, suppresses cancer progression through inhibition of TGF-β/Smad signaling. | Mol Cancer | 2022 | 35135542 | PubTator, text mining | PubMed |
| GM-CSF elicits antibodies to tumor-associated proteins when used as a prostate cancer vaccine adjuvant. | Cancer Immunol Immunother | 2022 | 35133464 | PubTator, text mining | PubMed |
| Cytoplasmic switch of ARS2 isoforms promotes nonsense-mediated mRNA decay and arsenic sensitivity. | Nucleic Acids Res | 2022 | 35104878 | PubTator, text mining | PubMed |
| LncRNAs LCETRL3 and LCETRL4 at chromosome 4q12 diminish EGFR-TKIs efficiency in NSCLC through stabilizing TDP43 and EIF2S1. | Signal Transduct Target Ther | 2022 | 35095099 | PubTator, text mining | PubMed |
| Proteomics Uncovers Novel Components of an Interactive Protein Network Supporting RNA Export in Trypanosomes. | Mol Cell Proteomics | 2022 | 35091090 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9775/papers?page=29